Related Experiment Video
Updated: Mar 25, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Management of schizophrenia with substance use disorders
Janice Lybrand1, Stanley Caroff
1Department of Psychiatry, Philadelphia VA Medical Center, Philadelphia, PA 19104, USA. janice.lybrand@va.gov
Abstract:
Around 50% of patients with schizophrenia develop a co-occurring substance use disorder involving alcohol or illicit substances at some time during their lives. The comorbid substance abuse will markedly affect the course of illness of schizophrenia. In this article, the authors review the epidemiology, theories of causation, effect on the course of illness, and treatment of co-occurring schizophrenia and substance use disorder.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia

